These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 27732770)

  • 1. Thromboelastographic monitoring of the effect of unfractionated heparin in healthy dogs.
    McLaughlin CM; Marks SL; Dorman DC; Motsinger-Reif A; Hanel RM
    J Vet Emerg Crit Care (San Antonio); 2017 Jan; 27(1):71-81. PubMed ID: 27732770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sonoclot® evaluation of single- and multiple-dose subcutaneous unfractionated heparin therapy in healthy adult dogs.
    Babski DM; Brainard BM; Ralph AG; Pittman JR; Koenig A
    J Vet Intern Med; 2012; 26(3):631-8. PubMed ID: 22435404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pilot study documenting increased thrombin generation following abrupt withdrawal of heparin therapy in healthy dogs.
    Mays EM; Dorman DC; McKendry C; Hanel RM
    J Vet Emerg Crit Care (San Antonio); 2018 Nov; 28(6):518-526. PubMed ID: 30303616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and pharmacodynamics of a therapeutic dose of unfractionated heparin (200 U/kg) administered subcutaneously or intravenously to healthy dogs.
    Diquélou A; Barbaste C; Gabaig AM; Trumel C; Abella-Bourges N; Guelfi JF; Bousquet Mélou A
    Vet Clin Pathol; 2005 Sep; 34(3):237-42. PubMed ID: 16134071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of unfractionated heparin on thrombelastographic analysis in healthy dogs.
    Pittman JR; Koenig A; Brainard BM
    J Vet Emerg Crit Care (San Antonio); 2010 Apr; 20(2):216-23. PubMed ID: 20487249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can an anti-Xa assay for unfractionated heparin be used to assess the presence of rivaroxaban in critical situations?
    Shin H; Koh EH; Lee GW; Song HN; Kim HY; Park S
    J Vasc Surg Venous Lymphat Disord; 2020 Sep; 8(5):741-747. PubMed ID: 32113855
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of point-of-care coagulation tests as alternatives to anti-Xa activity for monitoring the anticoagulant effects of rivaroxaban in healthy dogs.
    Lynch AM; Ruterbories LK; Griffith EH; Hanel RM; Stablein AP; Brooks MB
    J Vet Emerg Crit Care (San Antonio); 2021 Jan; 31(1):18-24. PubMed ID: 33118685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Coagulation effects of low molecular weight heparin compared with heparin in dogs considered to be at risk for clinically significant venous thrombosis.
    Scott KC; Hansen BD; DeFrancesco TC
    J Vet Emerg Crit Care (San Antonio); 2009 Feb; 19(1):74-80. PubMed ID: 19691587
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of thrombelastography for dosage monitoring of low molecular weight heparin and unfractionated heparin during hemodialysis.
    Shinoda T; Arakura H; Katakura M; Shirota T; Nakagawa S
    Artif Organs; 1990 Dec; 14(6):413-5. PubMed ID: 2177970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viscoelastic pharmacodynamics after dalteparin administration to healthy dogs.
    Brainard BM; Koenig A; Babski DM; Blong AE; Scherk JR
    Am J Vet Res; 2012 Oct; 73(10):1577-82. PubMed ID: 23013183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative trial of anti-factor Xa levels versus the activated partial thromboplastin time for heparin monitoring.
    Vandiver JW; Vondracek TG
    Hosp Pract (1995); 2013 Apr; 41(2):16-24. PubMed ID: 23545756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulant effects of repeated subcutaneous injections of high doses of unfractionated heparin in healthy dogs.
    Mischke RH; Schüttert C; Grebe SI
    Am J Vet Res; 2001 Dec; 62(12):1887-91. PubMed ID: 11763176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The detection of changes in heparin activity in the rabbit: a comparison of anti-xa activity, thrombelastography, activated partial thromboplastin time, and activated coagulation time.
    Nielsen VG
    Anesth Analg; 2002 Dec; 95(6):1503-6, table of contents. PubMed ID: 12456408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agreement between activated partial thromboplastin time and anti-Xa activity in critically ill patients receiving therapeutic unfractionated heparin.
    Ratano D; Alberio L; Delodder F; Faouzi M; Berger MM
    Thromb Res; 2019 Mar; 175():53-58. PubMed ID: 30708169
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activated Clotting Time (ACT) for Monitoring of Low-Dose Heparin: Performance Characteristics in Healthy Adults and Critically Ill Patients.
    Wehner JE; Boehne M; David S; Brand K; Tiede A; Bikker R
    Clin Appl Thromb Hemost; 2020; 26():1076029620975494. PubMed ID: 33350327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of viscoelastic coagulation testing to monitor low molecular weight heparin administration to healthy horses.
    Tennent-Brown BS; Epstein KL; Whelchel DD; Giguère S
    J Vet Emerg Crit Care (San Antonio); 2013; 23(3):291-9. PubMed ID: 23656212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of correlation between heparin dose and standard clinical monitoring tests in treatment with unfractionated heparin in critically ill children.
    Kuhle S; Eulmesekian P; Kavanagh B; Massicotte P; Vegh P; Lau A; Mitchell LG
    Haematologica; 2007 Apr; 92(4):554-7. PubMed ID: 17488668
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial thromboplastin time is more predictive of bleeding than anti-Xa levels in heparinized pediatric patients after cardiac surgery.
    Oladunjoye OO; Sleeper LA; Nair AG; Trenor CC; VanderPluym C; Kheir JN; Emani SM
    J Thorac Cardiovasc Surg; 2018 Jul; 156(1):332-340.e1. PubMed ID: 29709361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The monitoring of heparin administration by screening tests in experimental dogs.
    Mischke R; Jacobs C
    Res Vet Sci; 2001 Apr; 70(2):101-8. PubMed ID: 11356088
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of unfractionated heparin, low molecular weight heparin and danaparoid on the thromboelastogram (TEG): an in-vitro comparison of standard and heparinase-modified TEGs with conventional coagulation assays.
    Coppell JA; Thalheimer U; Zambruni A; Triantos CK; Riddell AF; Burroughs AK; Perry DJ
    Blood Coagul Fibrinolysis; 2006 Mar; 17(2):97-104. PubMed ID: 16479191
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.